[1]
|
Wheeler, A.P. and Bernard, G.R. (1999) Treating patients with severe sepsis. The New England Journal of Medicine, 340, 207-214. doi:10.1056/NEJM199901213400307
|
[2]
|
Parrillo, J.E., Parker, M.M., Natanson, C., Suffredini, A.F., Danner, R.L., Cunnion, R.E. and Ognibene, F.P. (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of Internal Medicine, 113, 227-242.
|
[3]
|
Letarte, J., Longo, C.J., Pelletier, J., Nabonne, B. and Fisher, H.N. (2002) Patient characteristics and costs of severe sepsis and septic shock in Quebec. Journal of Critical Care, 17, 9-49. doi:10.1053/jcrc.2002.33028
|
[4]
|
Chalfin, D.B., Holbein, M.E., Fein, A.M. and Carlon, G.C. (1993) Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA, 269, 249-254.
doi:10.1001/jama.1993.03500020083037
|
[5]
|
Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J. and Pinsky, M.R. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Critical Care Medicine, 29, 1303-1310.
doi:10.1097/00003246-200107000-00002
|
[6]
|
Perl, T.M., Dvorak, L., Hwang, T. and Wenzel, R.P. (1995) Long-term survival and function after suspected gramnegative sepsis. JAMA, 274, 338-345.
doi:10.1001/jama.1995.03530040066043
|
[7]
|
Heyland, D.K., Hopman, W., Coo, H., Tranmer, J. and McColl, M.A. (2000) Long-term health-related quality of life in survivors of sepsis: Short Form-36: A valid and reliable measure of health-related quality of life. Critical Care Medicine, 28, 3599-3605.
doi:10.1097/00003246-200011000-00006
|
[8]
|
Martin, G.S., Mannino, D.M., Eaton, S. and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine, 348, 1546-1554. doi:10.1056/NEJMoa022139
|
[9]
|
Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M. and Sibbald, W.J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655.
doi:10.1378/chest.101.6.1644
|
[10]
|
Salomao, R., Rigato, O., Pignatari, A.C., Freudenberg, M. A. and Galanos, C. (1999) Bloodstream infections: Epidemiology, pathophysiology and therapeutic perspectives. Infection, 27, 1-11. doi:10.1007/BF02565163
|
[11]
|
Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., Moreno, R., Lipman, J., Gomersall, C., Sakr, Y., et al. (2009) EPIC II group of investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA, 302, 2323-2329.
doi:10.1001/jama.2009.1754
|
[12]
|
Schultz, M.J., Knapp, S. and van der Poll, T. (2002) Regulatory role of alveolar macrophages and cytokines in pulmonary host defense. Yearbook of Intensive Care and Emergency Medicine, Springer Verlag, 65-76.
|
[13]
|
Wichterman, K.A., Baue, A.E. and Chaudry, I.H. (1980) Sepsis and septic shock—A review of laboratory models and a proposal. Journal of Surgical Research, 29, 189-201. doi:10.1016/0022-4804(80)90037-2
|
[14]
|
Deitch, E.A. (1998) Animal models of sepsis and shock: A review and lessons learned. Shock, 9, 1-11.
doi:10.1097/00024382-199801000-00001
|
[15]
|
Fink, M.P. and Heard, S.O. (1990) Laboratory models of sepsis and septic shock. Journal of Surgical Research, 49, 186-196. doi:10.1016/0022-4804(90)90260-9
|
[16]
|
Fink, M.P., Morrissey, P.E., Stein, K.L., Clement, R.E., Fiallo, V. and Gardiner, W.M. (1988) Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Circulatory Shock, 26, 41-57.
|
[17]
|
Mehrad, B. and Standiford, T.J. (1999) Role of cytokines in pulmonary antimicrobial host defense. Immunologic Research, 20, 15-27. doi:10.1007/BF02786504
|
[18]
|
Sewnath, M.E., Olszyna, D.P., Birjmohun, R., Ten Kate, F.J., Gouma, D.J. and van der Poll, T. (2001) IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. The Journal of Immunology, 166, 6323-6331.
|
[19]
|
Emerson Jr., T.E. and Gill, C.C. (1967) Effects of slow intravenous endotoxin infusion on hemodynamics and survival in dogs. Journal of Applied Physiology, 22, 874-877.
|
[20]
|
Fish, R.E. and Spitzer, J.A. (1984) Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: A unique model of chronic endotoxemia. Circulatory Shock, 12, 135-149.
|
[21]
|
Fish, R.E., Burns, A.H., Lang, C.H. and Spitzer, J.A. (1985) Myocardial dysfunction in a non-lethal, non-shock model of chronic endotoxemia. Circulatory Shock, 16, 241-252.
|
[22]
|
Fish, R.E., Lang, C.H. and Spitzer, J.A. (1986) Regional blood flow during continuous low-dose endotoxin infusion. Circulatory Shock, 18, 267-275.
|
[23]
|
Kurtz, H.J. and Quast, J. (1982) Effects of continuous intravenous infusion of Escherichia coli endotoxin into swine. American Journal of Veterinary Research, 43, 262-268.
|
[24]
|
Fink, M.P., Cohn, S.M., Lee, P.C., Rothschild, H.R., Deniz, Y.F., Wang, H., et al. (1989) Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: Evidence of gut ischemia in a normodynamic model of septic shock. Critical Care Medicine, 17, 641-646. doi:10.1097/00003246-198907000-00009
|
[25]
|
Breslow, M.J., Miller, C.F., Parker, S.D., Walman, A.T. and Traystman, R.J. (1987) Effect of vasopressors on organ blood flow during endotoxin shock in pigs. American Journal of Physiology, 252, 291-300.
|
[26]
|
Fink, M.P., Fiallo, V., Stein, K.L. and Gardiner, W.M. (1987) Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: Development of a new model of the clinical syndrome of hyperdynamic sepsis. Circulatory Shock, 22, 73-81.
|
[27]
|
Raetz, C.R. and Whitfield, C. (2002) Lipopolysaccharide endotoxins. Annual Review of Biochemistry, 71, 635-700.
doi:10.1146/annurev.biochem.71.110601.135414
|
[28]
|
Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Zahringer, U., Seydel, U. and Padova, D.F., et al. (1994) Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB Journal, 8, 217-225.
|
[29]
|
Hinshaw, L.B. (1984) Handbook of endotoxin: Pathophysiology of endotoxin, Vol. II. Elsevier/North Holland Biomedical, Amsterdam.
|
[30]
|
Suffredini, A.F., Fromm, R.E., Parker, M.M., Brenner, M. and Kovacs, J.A. (1989) The cardiovascular response of normal humans to the administration of endotoxin. The New England Journal of Medicine, 321, 280-287.
doi:10.1056/NEJM198908033210503
|
[31]
|
Raetz, C.R.H. (1990) Biochemistry of endotoxins. Annual Reviews in Biochemistry, 59, 129-170.
doi:10.1146/annurev.bi.59.070190.001021
|
[32]
|
Raetz, C.R.H. and Niedhardt, F.C. (1996) Escherichia coli and salmonella: Cellular and molecular biology. American Society for Microbiology, Washington, DC, 1035-1063.
|
[33]
|
Z?hringer, U., Lindner, B. and Rietschel, E.T. (1999) Endotoxin in health and disease. Marcel Dekker, Inc., New York, 93-114.
|
[34]
|
Brade, H., Opal, S.M., Vogel, S.N. and Morrison, D.C. (1999) Endotoxin in health and disease. Marcel Dekker, Inc., New York, 950.
|
[35]
|
Onishi, H.R., Pelak, B.A., Gerckens, L.S., Silver, L.L. and Kahan, F.M. (1996) Antibacterial agents that inhibit lipid a biosynthesis. Science, 274, 980-982.
doi:10.1126/science.274.5289.980
|
[36]
|
Vaara, M. (1993) Antimicrob. Agents Chemother, 37, 2255-2260. doi:10.1128/AAC.37.11.2255
|
[37]
|
Salomao, R., Brunialti, M.K., Rapozo, M.M., Baggio-Zappia, G.L., Galanos, C. and Freudenberg, M. (2012) Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock, 38, 227-242.
doi:10.1097/SHK.0b013e318262c4b0
|
[38]
|
Rietschel, E.Th. (1984) Handbook of endotoxin: Chemistry of endotoxin, Vol. I. Elsevier/North-Holland Biomedical, Amsterdam.
|
[39]
|
Galanos, C., Rictschel, E.Th., Liideritz, O. and Westphal, O. (1977) International review of biochemistry: Biochemistry of lipids II. University Park Press, Baltimore, 239-335.
|
[40]
|
Dinarello, C.A. (1986) Interleukin-1. Reviews of Infectious Diseases, 6, 51-95. doi:10.1093/clinids/6.1.51
|
[41]
|
Loppnow, H., Brade, H., Diirrbaum, I., Dinarello, C.A., Kusumoto, S., Rietschel, E.T. and Flad, H.D. (1989) IL-1 induction-capacity of defined lipopolysaccharide partial structures. The Journal of Immunology, 142, 3229-3238.
|
[42]
|
Beutler, B. and Cerami, A. (1988) The history, properties, and biological effects of cachectin. Biochemistry, 27, 7575-7582. doi:10.1021/bi00420a001
|
[43]
|
Old, L.J. (1988) Tumor necrosis factor. Scientific American, 258, 59-75. doi:10.1038/scientificamerican0588-59
|
[44]
|
Kiener, P.A., Marek, F., Rodgers, G., Lin, P.F., Warr, G. and Desiderio, J. (1988) Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. The Journal of Immunology, 141, 870-874.
|
[45]
|
Wolpe, S.D., Davatelis, G., Sherry, B., Beutler, B. and Hesse, D.G. (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. The Journal of Experimental Medicine, 167, 570-581. doi:10.1084/jem.167.2.570
|
[46]
|
Luderitz, O.A., Staub, M. and Westphal. O. (1966) Immunochemistry of O and R antigens of salmonella and related enterobacteriace. Bacteriological Reviews, 30, 192-255.
|
[47]
|
Johnson, K.G. and Perry, M.B. (1975) Improved techniques for the preparation of bacterial lipopolysaccharides. Canadian Journal of Microbiology, 22, 29-34.
doi:10.1139/m76-004
|
[48]
|
Adams, G.A. (1972) Lipopolysaccharides. Preparation from gram-negative bacteria. In: Whistler, R.L. and BeMille, J.N., Eds., Methods in Carbohydrate Chemistry, Academic Press, Inc., New York, 157-161.
|
[49]
|
Fensoma, H. and Gray, G.W. (1969) The chemical composition of lipopolysaccharide of Pseudonomas aeruginosa. Biochemical Journal, 114, 185-196.
|
[50]
|
Leive, L. and Morris, D. (1972) Isolation of lipopolysaccharides from bacteria. In: Ginsburg, N., Ed., Methods in Enzymology, 254-262.
|
[51]
|
Nishimura, L.S., Ferreira, L.C., Pacheco, A.B. and Guth, B.E. (1996) Relationship between outer membrane protein and lipopolysaccharide profiles and serotypes of enterotoxigenic Escherichia coli isolated in Brazil. FEMS Microbiology Letters, 143, 253-258.
doi:10.1111/j.1574-6968.1996.tb08489.x
|
[52]
|
Dogan, M.D., Ataoglu, H. and Akarsu, E.S. (2000) Effects of different serotypes of Escherichia coli lipopolysaccharides on body temperature in rats. Life Sciences, 67, 2319-2329. doi:10.1016/S0024-3205(00)00821-3
|
[53]
|
Nedrebo, T. and Reed, R.K. (2001) Different serotypes of endotoxin (lipopolysaccharide) cause different increases in albumin extravasation in rats. Shock, 18, 138-141.
doi:10.1097/00024382-200208000-00008
|
[54]
|
Jacobsen, S., Andersen, P.H., Toelboell, T. and Heegaard, P.M. (2004) Dose dependency and individual variability of the lipopolysaccharide-induced bovine acute phase protein response. Journal of Dairy Science, 10, 3330-3339.
doi:10.3168/jds.S0022-0302(04)73469-4
|